☰

Sources, Quality and Prices of Active Pharmaceutical Ingredients of Antiretroviral Drugs: Results of a 2012 WHO Survey

This document reports on a survey by WHO on the market for Active Pharmaceutical Ingredients (API) of antiretroviral (ARV) drugs, conducted in the first quarter of 2012. The information requested from the manufacturers included whether they produce ARV APIs, what is their API price, the regulatory status and pharmacopoeia standard of their products, their production capacity, storage conditions and whether they have an APIMF (API Master File) available or not. Thirteen manufacturers responded.

Approvisionnement, Assurance Qualité, Fixation des prix, Planification & Budgétisation, Sélection

  • Sous-catégories VIH/SIDA
  • Commodities Médicaments
  • Date de mise à jour 2012
  • Version
  • Développé par WHO
  • Quand l'utiliser This document reports on a survey by WHO on the market for Active Pharmaceutical Ingredients (API) of antiretroviral (ARV) drugs, conducted in the first quarter of 2012. The information requested from the manufacturers included whether they produce ARV APIs, what is their API price, the regulatory status and pharmacopoeia standard of their products, their production capacity, storage conditions and whether they have an APIMF (API Master File) available or not. Thirteen manufacturers responded.
  • Langues Anglais
  • Niveau d'utilisation Central
  • Forme PDF file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Coût none
  • Advantages n/a
  • Contraintes WHO has made every effort to ensure the accuracy of the information presented, but the readers should realize that manufacturing and production Capacity are a highly dynamic area, and that data can therefore never be complete. The data and information contained herein are being provided as is.
  • Disponibilité http://apps.who.int/iris/bitstream/10665/75172/1/9789241503778_eng.pdf
  • Remarques
  • Contact Contact AMDS, WHO. Email: amds@who.int
  • Submission date 2012-07-26 14:48:41